CytRx Announces Partial Clinical Hold On Main Drug' Big Buying Opportunity For Investors
November 18, 2014 at 14:36 PM EST
Aldoxorubicin receives a partial clinical hold from the FDA.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.